{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:47:00Z","timestamp":1784209620724,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.cancergencyto.2006.04.012","type":"journal-article","created":{"date-parts":[[2006,9,11]],"date-time":"2006-09-11T11:12:21Z","timestamp":1157973141000},"page":"16-23","source":"Crossref","is-referenced-by-count":32,"title":["Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors"],"prefix":"10.1016","volume":"170","author":[{"given":"Yulia","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas E.","family":"Horsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapio","family":"Pantzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E.","family":"Hogge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Nevill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Nantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia L.","family":"Toze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julye C.","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2006.04.012_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/gcc.2870040314","article-title":"Trisomy 8 in Philadelphia chromosome (Ph1)-negative cells in the course of Ph1-positive chronic myelocytic leukemia","volume":"4","author":"Casali","year":"1992","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/gcc.2870060414","article-title":"A second case of trisomy 8 in Philadelphia chromosome (Ph)-negative cells during the course of Ph-positive chronic myelocytic leukemia","volume":"6","author":"Bilhou-Nabera","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0165-4608(94)00197-9","article-title":"Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia","volume":"81","author":"Ariyama","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2141.1995.tb05223.x","article-title":"Acute myeloblastic leukaemia without Philadelphia chromosome developing after interferon therapy for chronic myelocytic leukaemia with Philadelphia chromosome","volume":"90","author":"Ohtsuka","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0925-5710(96)00469-0","article-title":"Philadelphia chromosome-negative cells with trisomy 8 after busulfan and interferon treatment of Ph-positive chronic myelogenous leukemia","volume":"64","author":"Izumi","year":"1996","journal-title":"Int J Hematol"},{"issue":"Suppl.2","key":"10.1016\/j.cancergencyto.2006.04.012_bib6","first-page":"72","article-title":"Acute blast transformation in CML patients still showing cytogenetic response to IFN-alpha n1 and the presence of cytogenetic abnormalities in PH negative cells","volume":"93","author":"Shepherd","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2400642","article-title":"Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases","volume":"11","author":"Fayad","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib9","first-page":"257b","article-title":"Non random chromosomal abnormalities in Ph-negative bone marrow (BM) cells from CML patients achieving major cytogenetic responses (MCR) with ST1571 (Gleevec)","volume":"98","author":"Gambacorti-Passeri","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib10","first-page":"253b","article-title":"Treatment with STI571 (Novartis R) in chronic myeloid leukemia (CML): unexpected hematological findings in a series of 26 patients","volume":"98","author":"Meunier","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib11","first-page":"585a","article-title":"The emergence of Philadelphia chromosome (Ph) negative, trisomy 8 positive cells in patients with chronic myelogenous leukemia (CML) treated with imatinib mesylate: clinical evidence for a multistep pathogenesis","volume":"100","author":"Feldman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib12","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/sj.leu.2402634","article-title":"Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8","volume":"16","author":"Andersen","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V100.2.435","article-title":"Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience","volume":"100","author":"Braziel","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib14","first-page":"260","article-title":"Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression","volume":"88","author":"Marktel","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.leu.2402813","article-title":"Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate","volume":"17","author":"Schoch","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.leu.2402791","article-title":"Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib","volume":"17","author":"Meeus","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.leu.2402848","article-title":"Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate","volume":"17","author":"O'Dwyer","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib18","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","article-title":"Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority","volume":"101","author":"Bumm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1034\/j.1600-0609.2003.00148.x","article-title":"Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI)","volume":"71","author":"Gozzetti","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.leu.2402842","article-title":"Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones","volume":"17","author":"Chee","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/sj.leu.2402877","article-title":"Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment","volume":"17","author":"Royer-Pokora","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib22","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2003-06-1943","article-title":"Chromosomal abnormalities in Ph- cells of patients on imatinib","volume":"102","author":"McMullin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib23","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2403037","article-title":"Myelodysplastic features developing in Philadelphia-negative cells during imatinib mesylate therapy for CML: report of a new case","volume":"17","author":"Mozziconacci","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib24","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cncr.11729","article-title":"Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase","volume":"98","author":"Medina","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-4608(03)00198-5","article-title":"Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases","volume":"147","author":"Herens","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2362.2004.01310.x","article-title":"Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with imatinib","volume":"34","author":"Cervetti","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ajh.20133","article-title":"Trisomy 8 in Philadelphia-negative cells during imatinib therapy","volume":"77","author":"Bernardeschi","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.leu.2403210","article-title":"Clonal evolution in Philadelphia chromosome negative cells following successful treatment with imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome","volume":"18","author":"Alimena","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.leu.2403345","article-title":"Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases","volume":"18","author":"Athanasiadou","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/sj.leu.2403361","article-title":"Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukemia patients treated with imatinib","volume":"18","author":"Guilbert-Douet","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib31","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/sj.leu.2403399","article-title":"Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia","volume":"18","author":"Terre","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib32","series-title":"The statistical analysis of failure time data","author":"Kalbfleisch","year":"1998"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc (B)"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2141.2004.05215.x","article-title":"Clonal karyotypic abnormalities in Philadelphia negative cells of CML patients treated with imatinib: is it under-reported and does it have any clinical significance","volume":"127","author":"O'Shea","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2006.04.012_bib36","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","article-title":"The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease","volume":"92","author":"Bose","year":"1998","journal-title":"Blood"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806002627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460806002627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T20:30:51Z","timestamp":1736541051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460806002627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0165460806002627"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.04.012","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}